HER2 Gene Mutation
19 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients (NCT05274048) | Fox Chase Cancer Center | 2022-06-24 |
| Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers (NCT06083662) | Korea University Guro Hospital | 2021-06-15 |
| Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas (NCT04620187) | Dana-Farber Cancer Institute | 2020-12-24 |
| The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor (NCT04179656) | Tianjin Medical University Second Hospital | 2019-12-01 |
| Her2-positive Lung Cancer Treated With Dedicated Drug (NCT03845270) | Intergroupe Francophone de Cancerologie Thoracique | 2019-05-17 |
| Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer (NCT03412383) | Peking Union Medical College | 2018-02-20 |
| Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) (NCT02979821) | Korean Association for the Study of Targeted Therapy | 2016-10-01 |
Track HER2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.